University of Virginia
Charlottesville, Virginia, 22908, United States
NCT Number: NCT02350660
Pilot study to assess the effect of oral immunotherapy on specific Immunoglobulin E (IgE) levels and antigen consumption in two distinct food allergies.
Looking for future studies?
Notify Me4 year–80 year
All sexes
Interventional
Not applicable
Charlottesville, Virginia, 22908, United States
In subjects with mammalian meat allergy, the effect of daily oral cow's milk on immune parameters and desensitization will be assessed. Similarly, in subjects with a peanut allergy the effects of low dose peanut flour will be assessed and comparisons between two distinct food allergies.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
daily consumption of cow's milk
peanut oral immunotherapy
Time frame: Following 36 months of maintenance oral immunotherapy, participants completed an open challenge at month 37
consumption of cow's milk or peanut flour at open challenge. This is a single time-point assessment; not measured repeatedly.
University of Virginia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07210320
Anaphylaxis, Food Allergy
St Louis, Missouri, United States
View Trial DetailsNCT02640014
Anaphylaxis, Food Hypersensitivity
Helsinki, Finland
View Trial DetailsNCT07027163
Anaphylaxis, Food Hypersensitivity
East Hanover, New Jersey, United States
View Trial DetailsNCT05177744
Asthma in Children, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Zagreb, City of Zagreb, Croatia
View Trial Details